January 11, 2024 C-Path to Lead New Task Force Aimed at Accelerating Drug Development for Mitochondrial and Inherited Metabolic Diseases Critical Path Institute (C-Path) today announced the launch of a task force focused on accelerating drug...
July 18, 2023 C-Path Integrates European Offices to Optimize Global Operations and Collaborative Partnerships AMSTERDAM and TUCSON, Ariz., July 18, 2023 — Critical Path Institute (C-Path) announced today the completion of the integration
April 26, 2023 C-Path Europe: A Global Vision of Success TUCSON, Ariz. and AMSTERDAM, April 26, 2023 — As an organization that generates regulatory-endorsed solutions and methodologies
December 20, 2022 C-Path’s Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System The iBox Scoring System is available for use in kidney transplant clinical trials as a novel secondary endpoint prognostic for all
June 20, 2020 C-Path’s Transplant Therapeutics Consortium Receives Acceptance of Letter of Intent for iBox Scoring System (Composite Biomarker Panel) as a Reasonably Likely Surrogate Endpoint Biomarker aims to streamline the development of novel therapies intended to improve long-term outcomes for kidney transplan